Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has received a nearly A$2.74 million research and development tax refund for the ...

Kincell Bio to acquire Imugene’s North Carolina manufacturing facility for up to $6M USD in upfront and milestone-driven payments over three years Kincell will expand its capacity and commitment to ...

Immune-oncology stalwart Imugene’s experience with the US Food and Drug Administration (FDA) highlights a lesson that all ...

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) will present updated clinical data on its lead cell therapy program at one of the world’s largest healthcare investment forums next week, as the company ...

SYDNEY & DUARTE, Calif.--(BUSINESS WIRE)--Imugene Ltd (ASX:IMU), an immuno-oncology company and City of Hope, a world-renowned independent cancer research and treatment center near Los Angeles, today ...

Imugene Limited has announced the dosing of the first Australian patient in its Phase 1b trial of azer-cel, a promising allogeneic CAR T-cell therapy, at the Royal Prince Alfred Hospital in Sydney.

Imugene Ltd ((IUGNF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Imugene Limited has secured a significant capital boost of up to A$46 million through the issuance of convertible notes and warrants to CVI Investments Inc. This funding is set to support the ...

SYDNEY and SHANGHAI, Nov. 27, 2025 /PRNewswire/ -- Imugene Ltd (ASX:IMU), a clinical-stage immuno-oncology company, and JW Therapeutics (Shanghai) Co., LTD (HKEX:2126), a leading biotechnology company ...

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the ...

SYDNEY, Australia and FLORHAM PARK, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Imugene Ltd (“Imugene”) (ASX: IMU), a clinical stage immuno-oncology company and ...

Imugene Ltd (ASX:IMU), an immuno-oncology company and City of Hope, a world-renowned independent cancer research and treatment center near Los Angeles, today announced they have entered into a ...